跳至主要内容
临床试验/CTRI/2024/09/073876
CTRI/2024/09/073876尚未招募2 期

Clinical study to evaluate the effect of virechana karma in Dyslipidemia

priya meena1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月23日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
relief in following objective parameters

研究概览

简要总结

The study is single arm open label clinical trial to evaluate the effect of virechana karma in dyslipidemia for the age group 20 to 60 years for 60 days. study will be conducted at UAU, Gurukul campus, haridwar for 40 patients.Assessment will be done on the basis of objective criteria. Study will be conducted at OPD/IPD level of panchakarma.virechana will be conducted once in a week for  2 months. The assesment will be done after one month of completion of treatment and result obtained will be tabulated and statistically analyzed using appropriate test.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients fit for Virechana Karma S.cholesterol -more than 180mg/dl S. triglyceride.
  • more than 150mg/dl S.LDL.
  • more than 110mg/dl S.VLDL.
  • more than 41mg/dl S.HDL.
  • less than 40mg/d.

排除标准

  • Age less than 20 years or more than 60 years.
  • Patients having serious cardiac problems such as myocardial infarction, cardiac failure,etc.
  • Patients having serious renal disease.
  • Drug-induced hyperlipidemia e.g. glucocorticoid-induced.
  • Patients having a major illness like uncontrolled DM.
  • Pregnant and lactating females.

结局指标

主要结局

relief in following objective parameters

时间窗: 8 weeks

Serum cholesterol more than 180mg/dl

时间窗: 8 weeks

Serum triglyceride more than 150mg/dl

时间窗: 8 weeks

Serum LDL more than 110mg/dl

时间窗: 8 weeks

Serum VLDL more than 41mg/dl

时间窗: 8 weeks

Serum HDL less than 40mg/dl

时间窗: 8 weeks

次要结局

  • To improve quality of life(2 months)

研究者

发起方
priya meena
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Priya Meena

UAU, Gurukul campus

研究点 (1)

Loading locations...

相似试验